In vivo pharmacokinetic applicability of a simple and validated HPLC method for orally administered trans-resveratrol loaded polymeric nanoparticles to rats

Journal of Pharmaceutical Investigation

Volumn 44, Issue 2, 2014, Pages 69-78

  Singh, Gurinder ^a   Pai, Roopa S ^a   Pandit, Vinay ^a  

^a AL AMEEN COLLEGE OF PHARMACY   (India)

Author keywords

HPLC; Nanoparticles; Pharmacokinetic study; Trans resveratrol

Indexed keywords

CATECHIN; NANOPARTICLE; RESVERATROL;

ACCURACY; ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CHROMATOGRAPH; CONTROLLED STUDY; DRUG DETERMINATION; DRUG DOSAGE FORM COMPARISON; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LINEARITY; MALE; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN PRECIPITATION; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RAT; SELECTIVITY; SENSITIVITY; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; SYSTEM SUITABILITY; VALIDATION PROCESS;

EID: 84897100443     PISSN: 20935552     EISSN: 20936214     Source Type: Journal    
DOI: 10.1007/s40005-013-0105-0     Document Type: Article

References (27)

1. Amidon GL, Lennernäs H, Shah VP, Crison JR (1995) A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12: 413-420.
2. Amri A, Chaumeil JC, Sfar S, Charrueau C (2012) Administration of resveratrol: what formulation solutions to bioavailability limitations. J Control Release 158: 182-193.
3. Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M, Arichi S (1982) Effects of stilbene components of the roots of. Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. Chem Pharm Bull 30: 1766-1770.
4. Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5: 493-506.
5. Bernardesa DC, Poppib RJ, Sena MM (2010) Direct determination of trans-resveratrol in human plasma by spectrofluorimetry and second-order standard addition. Talanta 82: 640-645.
6. Boocock DJ, Patel KR, Faust GES, Normolle DP, Marczylo TH, Crowell JA, Brenner DE, Booth TD, Gescher A, Steward WP (2007) Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography. J Chromatogr B 848: 182-187.
7. Cantos E, Espin JC, Fernandez MJ, Oliva J, Tomas-Barberan FA (2003) Postharvest UV-C-irradiated grapes as a potential source for producing stilbene-enriched red wines. J Agric Food Chem 51: 1208-1214.
8. Chen X, He H, Wang G, Yang B, Ren W, Ma L, Yu Q (2007) Stereospecific determination of cis- and trans-resveratrol in rat plasma by HPLC: application to pharmacokinetic studies. Biomed Chromatogr 21: 257-265.
9. Das S, Ng KY (2011) Quantification of trans-resveratrol in rat plasma by a simple and sensitive high performance liquid chromatography method and its application in pre-clinical study. J Liq Chromatogr Relat Technol 34: 1399-1414.
10. Delmas D, Lancon A, Colin D, Jannin B, Latruffe N (2006) Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Curr Drug Targets 7: 423-442.
11. Gao J, Zhong D, Duan X, Chen X (2007) Liquid chromatography/negative ion electrospray tandem mass spectrometry method for the quantification of rosuvastatin in human plasma: application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 856: 35-40.
12. He H, Chen X, Wang G, Wang J, Davey AK (2006) High-performance liquid chromatography spectrometric analysis of trans-resveratrol in rat plasma. J Chromat B 832: 177-180.
13. Juan ME, Lamuela-Raventos RM, Torre-Boronat DL, Planas JM (1999) Determination of trans-resveratrol in Plasma by HPLC. Anal Chem 71: 747-750.
14. Juan ME, Maijo M, Planas JM (2010) Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC. J Pharm Biomed Anal 51: 391-398.
15. Kakkara V, Singh S, Singla D, Sahwney S, Chauhan AS, Singh G, Kaur IP (2010) Pharmacokinetic applicability of a validated liquid chromatography tandem mass spectroscopy method for orally administered curcumin loaded solid lipid nanoparticles to rats. J Chromat B 878: 3427-3431.
16. Kim S, Kiong NGW, Dong Y, Das S, Tan RBH (2012) Preparation and physicochemical characterization of trans-resveratrol nanoparticles by temperature-controlled antisolvent precipitation. J Food Eng 108: 37-42.
17. Kristl J, Teskac K, Caddeo C, Abramovic Z, Sentjurc M (2009) Improvement of cellular stress response on resveratrol in liposomes. Eur J Pharm Biopharm 73: 253-259.
18. Langcake P, Pryce RJ (1976) The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol Plant Pathol 9: 77-86.
19. Lopez NJM, Nunez DE, Perez LAJ, Barrachina AC, Cuadra CP (2006) Determination of stoichiometric coefficients and apparent formation constants for β-cyclodextrin complexes of trans-resveratrol using reversed-phase liquid chromatography. J Chromatogr A 1135: 158-165.
20. Martins SM, Wendling T, Goncalves VMF, Sarmento B, Ferreira DC (2012) Development and validation of a simple reversed-phase HPLC method for the determination of camptothecin in animal organs following administration in solid lipid nanoparticles. J Chromat B 880: 100-107.
21. Mittal G, Sahana DK, Bhardwaj V, Kumar MNVR (2007) Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release 119: 77-85.
22. Ortuno J, Covas MI, Farre M, Pujadas M, Fito M, Khymenets O, Lacueva CA, Roset P, Joglar J, Lamuela-Raventos RM, Torre RDL (2010) Matrix effects on the bioavailability of resveratrol in humans. Food Chem 120: 1123-1130.
23. Singh G, Pai RS, Pandit V (2012) Development and validation of a HPLC method for the determination of trans-resveratrol in spiked human plasma. J Adv Pharm Tech Res 3: 130-135.
24. The United States Pharmacopoeia, (2008) USP31-NF26, 1225 752.
25. Touzet O, Philips A (2010) Resveratrol protects against protease inhibitor-induced reactive oxygen species production, reticulum stress and lipid raft perturbation. AIDS 24: 1437-1447.
26. US DHHS, FDA, CDER. Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine, 2001. www. fda. gov/cder/guidance/index. htm. Accessed 11 Feb 2013.
27. Vian MA, Tomao V, Gallet S, Coulomb PO, Lacombe JM (2005) Simple and rapid method for cis- and trans-resveratrol and piceid isomers determination in wine by high-performance liquid chromatography using Chromolith columns. J Chromatogr A 1085: 224-229.